NOT-DK-18-018: Notice of Clarification of Eligible Individuals [Program Director(s)/Principal Investigator(s)] for RFA-DK-18-009, Gastrointestinal Mechanisms Contributing to HIV Pathogenesis (R01 Clinical Trial Not Allowed)

Notice of Clarification of Eligible Individuals [Program Director(s)/Principal Investigator(s)] for RFA-DK-18-009, Gastrointestinal Mechanisms Contributing to HIV Pathogenesis (R01 Clinical Trial Not Allowed)

Notice Number: NOT-DK-18-018

Key Dates
Release Date: July 9, 2018

Related Announcements
RFA-DK-18-009

Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

The purpose of this Notice is to correct language in Section III.1 Eligibility Information, Eligible Applicants, Program Directors/Principal Investigators [PD(s)/PI(s)] to clarify that at least one PI with expertise in an aspect of gastrointestinal pathobiology is required.

Current Language:

Projects submitted to this FOA must propose multiple PDs/PIs and must include at least one PD/PI whose expertise is primarily on an aspect of HIV infection related to the proposed project and at least one PD/PI with appropriate expertise in an aspect of pathobiology.

Revised Language:

All other aspects of this Funding Opportunity Announcement remain the same.

Inquiries

Please direct all inquiries to:

Peter J. Perrin, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-451-3759
Email: [email protected]